ID

12009

Descrizione

Safety and Efficacy Study of AS101 to Treat Elderly Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01010373

collegamento

https://clinicaltrials.gov/show/NCT01010373

Keywords

versioni (3)
  1. 01/09/15 01/09/15 -
  2. 13/04/21 13/04/21 - Dr. rer. medic Philipp Neuhaus
  3. 18/11/21 18/11/21 -
Titolare del copyright

ODM derived from: https://clinicaltrials.gov/show/NCT01010373

Caricato su

1 settembre 2015

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

  • i più nuovi
  • i più vecchi
  • Popolare
  • i più nuovi
    • i più nuovi
    • i più vecchi
    • Popolare

Non ci sono commenti

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Acute Myeloid Leukemia NCT01010373

Inglese

Eligibility Acute Myeloid Leukemia NCT01010373

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

confirmed diagnosis of primary aml or aml transformed myelodysplastic syndrome (mds) with fab classification other than m3 as proven by bone marrow aspiration.
Descrizione

myelodysplastic syndrome; bone marrow; diagnosis; aspiration; confirmed; other; primary; fab

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C3463824
UMLS CUI [1,2]
|C0023467
age ≥60 years.
Descrizione

age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
ecog performance status of 0-2 (karnofsky >60%).
Descrizione

ecog performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
adequate renal functions: serum creatinine < 2 times the upper limit of normal (uln).
Descrizione

upper limit of normal (sgpt); upper limit of normal (sgot); serum creatinine; renal function; uln

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0232804
adequate hepatic function: serum ast and alt ≤ 3 x uln.
Descrizione

hepatic function; serum; ast; uln; alt

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0232741
patients with reproductive potential must use an effective contraceptive method through the study. patients must receive contraceptive and/or fertility counseling prior to entering the study, i.e., information on sperm banking, etc.
Descrizione

contraceptive; method; study

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0700589
Exclusion Criteria
Descrizione

Exclusion Criteria

patients receiving any other investigational agents.
Descrizione

other; agents

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0013230
symptomatic cns involvement.
Descrizione

cns involvement; symptomatic

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0449389
history of pancreatitis or active alcohol abuse.
Descrizione

alcohol abuse; pancreatitis; active

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0085762
UMLS CUI [2]
C0030305
histologic diagnosis of fab m3 aml.
Descrizione

diagnosis; fab

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0023487
life expectancy of less than 1 month.
Descrizione

life expectancy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0023671
patient receives myelotarg (ozogamicin gemtuzumab).
Descrizione

Mylotarg

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0876099
use of hematopoietic growth factors such as g-csf within 1 week prior to treatment initiation.
Descrizione

growth factors; treatment; g-csf; week

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0079490
pregnant or lactating females.
Descrizione

pregnant or lactating

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0549206
patient has known human immunodeficiency virus (hiv) infection or known hiv-related malignancy; patient has active hepatitis a, b or c infection.
Descrizione

human immunodeficiency virus; active hepatitis; hepatitis a; malignancy; infection; related; hiv

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019682
UMLS CUI [2]
C0019159
UMLS CUI [3]
C0348211
active, uncontrolled, systemic infection considered opportunistic, life threatening, or of clinical significance at the time of treatment, or any severe concurrent disease which, in the opinion of the investigator, would make the patient inappropriate for trial entry.
Descrizione

systemic infection; life threatening; investigator; treatment; clinical; disease; severe; active; entry; time

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0243026
UMLS CUI [2]
C1517874
the patient has had congestive heart failure - new york heart association (chf-nyha) grade ii or higher, and/or myocardial infarction within the last 12 months, or any cardiac disorder which, in the opinion of the investigator, could put the patient at risk of clinically relevant arrhythmia.
Descrizione

new york heart association classification; congestive heart failure; myocardial infarction; cardiac disorder; investigator; arrhythmia; grade; last; chf

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0018802
UMLS CUI [2]
C0027051
Ritorna all'inizio della pagina

Similar models

Eligibility Acute Myeloid Leukemia NCT01010373

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
myelodysplastic syndrome; bone marrow; diagnosis; aspiration; confirmed; other; primary; fab
Item
confirmed diagnosis of primary aml or aml transformed myelodysplastic syndrome (mds) with fab classification other than m3 as proven by bone marrow aspiration.
boolean
C3463824 (UMLS CUI [1,1])
|C0023467 (UMLS CUI [1,2])
age
Item
age ≥60 years.
boolean
C0001779 (UMLS CUI [1])
ecog performance status
Item
ecog performance status of 0-2 (karnofsky >60%).
boolean
C1520224 (UMLS CUI [1])
upper limit of normal (sgpt); upper limit of normal (sgot); serum creatinine; renal function; uln
Item
adequate renal functions: serum creatinine < 2 times the upper limit of normal (uln).
boolean
C0232804 (UMLS CUI [1])
hepatic function; serum; ast; uln; alt
Item
adequate hepatic function: serum ast and alt ≤ 3 x uln.
boolean
C0232741 (UMLS CUI [1])
contraceptive; method; study
Item
patients with reproductive potential must use an effective contraceptive method through the study. patients must receive contraceptive and/or fertility counseling prior to entering the study, i.e., information on sperm banking, etc.
boolean
C0700589 (UMLS CUI [1])
other; agents
Item
patients receiving any other investigational agents.
boolean
C0013230 (UMLS CUI [1])
cns involvement; symptomatic
Item
symptomatic cns involvement.
boolean
C0449389 (UMLS CUI [1])
alcohol abuse; pancreatitis; active
Item
history of pancreatitis or active alcohol abuse.
boolean
C0085762 (UMLS CUI [1])
C0030305 (UMLS CUI [2])
diagnosis; fab
Item
histologic diagnosis of fab m3 aml.
boolean
C0023487 (UMLS CUI [1])
life expectancy
Item
life expectancy of less than 1 month.
boolean
C0023671 (UMLS CUI [1])
Mylotarg
Item
patient receives myelotarg (ozogamicin gemtuzumab).
boolean
C0876099 (UMLS CUI [1])
growth factors; treatment; g-csf; week
Item
use of hematopoietic growth factors such as g-csf within 1 week prior to treatment initiation.
boolean
C0079490 (UMLS CUI [1])
pregnant or lactating
Item
pregnant or lactating females.
boolean
C0549206 (UMLS CUI [1])
human immunodeficiency virus; active hepatitis; hepatitis a; malignancy; infection; related; hiv
Item
patient has known human immunodeficiency virus (hiv) infection or known hiv-related malignancy; patient has active hepatitis a, b or c infection.
boolean
C0019682 (UMLS CUI [1])
C0019159 (UMLS CUI [2])
C0348211 (UMLS CUI [3])
systemic infection; life threatening; investigator; treatment; clinical; disease; severe; active; entry; time
Item
active, uncontrolled, systemic infection considered opportunistic, life threatening, or of clinical significance at the time of treatment, or any severe concurrent disease which, in the opinion of the investigator, would make the patient inappropriate for trial entry.
boolean
C0243026 (UMLS CUI [1])
C1517874 (UMLS CUI [2])
new york heart association classification; congestive heart failure; myocardial infarction; cardiac disorder; investigator; arrhythmia; grade; last; chf
Item
the patient has had congestive heart failure - new york heart association (chf-nyha) grade ii or higher, and/or myocardial infarction within the last 12 months, or any cardiac disorder which, in the opinion of the investigator, could put the patient at risk of clinically relevant arrhythmia.
boolean
C0018802 (UMLS CUI [1])
C0027051 (UMLS CUI [2])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial